Brain Cancer
Routine Genomic Profiling Could Improve Diagnosis of Aggressive Brain Cancers, Patient Outcomes
Premium
A study by UCSF researchers has shown the benefits of offering all brain cancer patients the chance to get genomic sequencing.
Brain Cancer Canada Funds Development of New Dx Sequencing Assay at St. Michael's Hospital
The group plans to develop and implement a custom gene sequencing assay intended to help rapidly diagnose brain cancers and inform molecularly targeted treatment.
Black Diamond Therapeutics Doses First Patient in Recurrent EGFR-Mutant Glioblastoma, NSCLC Trial
The trial is designed to assess BDTX-1535 for patients with brain or lung cancers harboring EGFR alterations that haven't responded to standard treatment.
Mustang Bio to Study CAR T-Cell, Oncolytic Virus Combination for Recurrent Brain Cancer Patients
The firm will launch a Phase I trial of the C134 oncolytic virus MB-108 followed by the autologous 13Rα2-targeted CAR T-Cell therapy MB-101 for advanced glioblastoma.
NIH Launches New Childhood Cancer Genomics Program
Pediatric and young adult patients treated at facilities affiliated with the NCI-sponsored Children's Oncology Group gain new, broad access to tumor molecular profiling.